Convertible Credit Line and Unsecured Convertible Note Extension #2 AgreementConvertible Credit Line and Unsecured Convertible Note Extension • January 18th, 2023 • Orgenesis Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 18th, 2023 Company IndustryThis Convertible Credit Line and Unsecured Convertible Note Extension#2 Agreement (“Extension#2”) is entered into as of January 12, 2023 (the “Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Yosef Dotan (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”
Convertible Credit Line Extension AgreementConvertible Credit Line Extension Agreement • January 18th, 2023 • Orgenesis Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 18th, 2023 Company IndustryThis Convertible Credit Line Extension Agreement (“Extension”) is entered into as of January 12, 2023 (the “Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Aharon Lukach (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties.”
Convertible Loans and Unsecured Convertible Notes Extension #2 AgreementConvertible Loans and Unsecured Convertible Notes Extension Agreement • January 18th, 2023 • Orgenesis Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 18th, 2023 Company IndustryThis Convertible Loans and Unsecured Convertible Notes Extension#2 Agreement (“Extension#2”) is entered into as of January 12, 2023 (the “Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Yehuda Nir (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”